LGALS3 and chronic myelogenous leukemia, BCR-ABL1 positive: The binding mechanism of ligands to galectin-3 is in many cases unknown, emphasising the importance of further studies to better understand the binding affinity of galectin-3 and its interaction with protein-bound CML.